Pre-clinical validation of an RNA-based precision oncology platform for patient-therapy alignment in a diverse set of human malignancies resistant to standard treatments
GSE197763No linked publication
Overview
- Modality
- Bulk RNA-seq
- Sample count
- 102
- Patient count
- Not reported
- Institution
- Columbia University Irving Medical Center
- Corresponding author
- Prabhjot S Mundi, Mariano J Alvarez
- Platform
- Illumina NextSeq 500 (GPL18573), Illumina NovaSeq 6000 (GPL24676)
- Access type
- open
- Tissue preservation
- Not reported
- WHO edition
- Not reported
Cohort detail
- Grade breakdown
- G1: 51 G2: 38 G3: 6
- Sex distribution
- Not reported
- Age distribution
- Not reported
- Anatomic location
- Not reported
- Brain invasion
- Not reported
- Normal/control tissue
- Benign arachnoid tissue (n=7)
Priority attributes
WHO grade breakdown availableLarge cohort (top quartile)
Publications
No publication linked.
Sources
- GEOhttps://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE197763